Search results
Results From The WOW.Com Content Network
On May 22, the House Armed Services Committee approved its version of the 2025 National Defense Authorization Act, by a 57–1 vote. [6] As passed by the Committee, the bill included the Pentagon's controversial "Legislative Proposal 480", transferring Air National Guard space units to the Space Force; however, the Committee accepted an amendment proposed by Joe Wilson (R‑SC), watering down ...
The National Defense Authorization Act for Fiscal Year 2022 (S. 1605; NDAA 2022, Pub.L. 117-81) is a United States federal law which specifies the budget, expenditures and policies of the U.S. Department of Defense (DOD) for fiscal year 2022. Analogous NDAAs have been passed annually for 60 years.
2021 William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021: Pub. L. 116–283 (text) COMPS-16736 Formally named after William McClellan "Mac" Thornberry, a long-term Congressman, and ranking member of the House Armed Services Committee. 2022 National Defense Authorization Act for Fiscal Year 2022
Overridden by the Senate and became law on January 1, 2021 The William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 (NDAA 2021) is a United States federal law which specifies the budget, expenditures and policies of the U.S. Department of Defense (DOD) for fiscal year 2021.
Language on the topic of UAP was also included in the previous 2022 NDAA (e.g. 50 U.S.C. § 3373), the Intelligence Authorization Act for Fiscal Year 2022 (e.g. 50 U.S.C. § 3373a), as well as an accompanying Senate Select Committee on Intelligence report for the Intelligence Authorization Act for Fiscal Year 2021 (i.e. S. Rept. 116-233).
Language on the topic of UFO/UAP was also included in the previous 2023 NDAA (e.g. 50 U.S.C. § 3373b), the 2022 NDAA (e.g. 50 U.S.C. § 3373), the Intelligence Authorization Act for Fiscal Year 2022 (e.g. 50 U.S.C. § 3373a), as well as an accompanying Senate Select Committee on Intelligence report for the Intelligence Authorization Act for ...
Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced that its ongoing rolling Biologics License Application (BLA) submission to the FDA for lifileucel is expected to be completed in the first ...
(1) IN GENERAL.—Subject to paragraph (2), for fiscal years 2022 and 2023, the President may authorize the United States Government to lend or lease defense articles to the Government of Ukraine or to governments of Eastern European countries impacted by the Russian Federation’s invasion of Ukraine to help bolster those countries' defense ...